STRAW+10 provides a detailed and comprehensive system for tracking and assessing the phases of menopause. At various stages, it highlights key hormonal changes, such as fluctuations in estradiol levels and FSH levels during menopause, which are indicators of the menopausal transition.
As a result, it offers valuable insights and a more precise method for evaluating menopausal changes. The STRAW+10 system enhances the ability of researchers and healthcare providers to effectively assess and manage the menopausal journey, thereby making it an essential tool in everyday medical practice.
What is STRAW+10?
To elaborate, the STRAW+10 (STRAW plus 10 years) system offers a structured sequence for understanding reproductive aging in women. It divides the process into three phases and seven sub-stages, thus providing an in-depth method for assessing the progression from the reproductive years, through perimenopause (menopause transition), and into postmenopause.
In order to develop this system, the STRAW+10 workshop, held in Washington, D.C. in 2011, brought together 41 experts in female reproductive aging. Participants included researchers and clinicians from leading institutions in the U.S., Canada, Australia, the Netherlands, and South Africa.
Notable contributors represented several NIH-funded studies, such as the Study of Women’s Health Across the Nation (SWAN), the Michigan Bone Health and Metabolism Study (MBHMS), the Seattle Midlife Women’s Health Study (SMWHS), the Biodemographic Models of Reproductive Aging (BIMORA), the Penn Ovarian Aging Study (POAS), and the Melbourne Women’s Midlife Health Project (MWMHP).
Hormonal Changes Across Menopausal Stages
To achieve a deeper understanding of these changes, participants reviewed scientific advances in the hypothalamic-pituitary-ovarian (HPO) function before and after the final menstrual period (FMP). Additionally, they examined changes in menstrual, endocrine, and ovarian indicators of reproductive aging, including antimüllerian hormone (AMH), inhibin-B, follicle-stimulating hormone (FSH), and antral follicle count (AFC).
HPO is a hormone system that controls a woman’s reproductive cycles. It involves three parts: hypothalamus, pituitary gland and ovaries.
These parts work together like a team, sending hormone signals back and forth. This teamwork controls periods, egg release, and prepares the body for possible pregnancy.
Consequently, these discussions clarified how AMH and inhibin-B signal fertility decline and ovarian aging, leading to the development of the STRAW+10 system.
However, despite significant progress in understanding ovarian ageing since the original STRAW in 2001, important gaps in scientific knowledge still remain.
Why Know the Phases of Menopause
While the information from the STRAW+10 workshop was primarily intended to help researchers and healthcare professionals better understand and manage the phases of menopause, it is important to note that it can also empower women by giving them a better understanding of the changes occurring in their bodies, including various hormone imbalances, such as changes in estradiol levels and FSH levels during menopause.
Furthermore, this knowledge, in turn, can help women engage more actively in their healthcare, make informed decisions about managing their menopausal journey, and communicate more effectively with their doctors.
Empowerment Through Knowledge
First and foremost, understanding the STRAW+10 system helps to demystify the various phases of menopause, and also sheds light on the effects of conditions like low estrogen. Ultimately, this clarity can reduce anxiety and foster a greater sense of control over one’s health journey.
Communication with Healthcare Providers
With an understanding of the STRAW+10 system, women can ask informed questions and have more productive discussions with their doctors about topics like FSH levels during menopause. This knowledge enables them to better grasp the advice they receive, which is tailored to their specific stage, taking into account their unique hormones and menopause profile.
Personalised Healthcare
Because the STRAW+10 system provides a detailed understanding of the phases of menopause, it enables more personalised healthcare. By offering a clear picture of each stage, it helps healthcare providers tailor treatments and lifestyle recommendations more precisely. Therefore this targeted approach can better address individual needs, including managing low estrogen and menopause symptoms, as well as considering their long-term effects.
Empowerment Through Knowledge
Understanding the STRAW+10 system helps to demystify the various stages and sheds light on the effects of conditions like low estrogen. This clarity can reduce anxiety and foster a greater sense of control over one’s health journey.
Communication with Healthcare Providers
With an understanding of the STRAW+10 system, women can ask informed questions and have more productive discussions with their doctors about topics like FSH levels during menopause. This knowledge enables them to better grasp the advice they receive, which is tailored to their specific stage, taking into account their unique hormones and menopause profile.
Personalised Healthcare
The STRAW+10 system provides a detailed understanding of the phases of menopause, enabling more personalised healthcare. By offering a clear picture of each stage, it helps healthcare providers tailor treatments and lifestyle recommendations more precisely according to the specific phases of menopause.. This targeted approach can better address individual needs, including managing low estrogen and menopause symptoms, as well as considering their long-term effects.
Practical Tips for Navigating Menopause Phases:
Track Menstrual Cycles:
To begin with, keep a detailed record of menstrual cycles, including frequency, duration, and other menopause symptoms like mood swings and sleepless nights. By doing so this data can assist healthcare providers in tailoring care throughout the phases of menopause.
Track Menstrual Cycles:
Keep a detailed record of menstrual cycles, including frequency, duration, and other menopause symptoms like mood swings and sleepless nights. This data can assist healthcare providers in tailoring care.
Understanding the science behind menopause can help you feel more in control.
Understanding the Phases of Menopause
While the average age for reaching menopause is 51, it can naturally occur anytime between the ages of 40 to 58. To clarify this process, the STRAW+10 system offers a structured approach to reproductive aging, dividing a woman’s life into three main phases: reproductive, menopausal transition, and postmenopause.
By clearly defining these phases and their specific stages, STRAW+10 helps women and healthcare providers identify where they are in the process, thereby enabling a more personalised and effective management of menopause symptoms and health plans.
It’s important to mention that while most women typically move steadily from one stage to the next, some may experience a “see-saw” effect, moving back and forth between stages or even skipping a stage entirely.
STRAW+10 System: Phases and Stages Overview
3 Phases of Reproductive Aging
-
- Reproductive Phase
This phase includes the early, peak, and late reproductive stages. In the late reproductive stage, changes in the menstrual cycle and hormone levels occur, fertility begins to decline. - Menopausal Transition Phase
During this phase, menstrual cycles become irregular, and symptoms like hot flashes and mood swings often appear. Hormonal changes, such as low estrogen and fluctuating FSH levels, are common. - Postmenopause Phase
This phase begins after your final menstrual period. Hormone levels, including estradiol and FSH, stabilize, but the risk of issues like osteoporosis and cardiovascular disease can increase due to low estrogen levels.
- Reproductive Phase
These phases included a total of seven stages centred around the final menstrual period (FMP, Stage 0).
-
-
Reproductive Phase:
Duration: variable
The Reproductive stage is characterised by regular menstrual cycles and is divided into three sub-stages:
-
- Stage -5: Early reproductive – (Typically teens to late 20’s)
This stage begins with menarche (first menstruation). Menstrual cycles are often irregular and unpredictable during the first few years. Cycle length can vary widely, and anovulatory cycles (cycles without ovulation) are common. As time progresses, cycles generally become more regular, though some variability may persist. - Stage -4: Peak reproductive – (Late teens to late 20’s)
During this phase, menstrual cycles typically stabilise and become more regular. Most cycles are ovulatory, and women experience their peak fertility. Cycle length usually settles into a consistent pattern, often ranging from 21 to 35 days. - Stages -3b / 3a: Late reproductive – (Early 30’s to early 40’s)
During this stage, when fertility starts to decline, cycles remain regular, but subtle changes may begin to occur. This stage is divided into two sub-stages.
- Stage -5: Early reproductive – (Typically teens to late 20’s)
-
-
- Stage 3b: Menstrual cycles remain regular and FSH levels are normal at this stage, but other indicators of ovarian health, such as AMH (Anti-Müllerian Hormone) and AFC (antral follicle counts), start to decline. This decrease, along with low levels of inhibin-B observed in some studies, signals the early signs of diminishing egg supply.
- Stage 3a: Subtle changes in menstrual cycle begin, particularly shorter cycles. FSH levels increase above normal. AMH, AFC, and inhibin-B remain low.
- Stage 3b: Menstrual cycles remain regular and FSH levels are normal at this stage, but other indicators of ovarian health, such as AMH (Anti-Müllerian Hormone) and AFC (antral follicle counts), start to decline. This decrease, along with low levels of inhibin-B observed in some studies, signals the early signs of diminishing egg supply.
-
-
Menopausal Transition Phase (PERIMENOPAUSE):
The menopausal transition is a critical phase that marks the shift from the reproductive years to menopause. It is divided into two key stages:
-
- Stage -2: Early Menopause transition – (Early to mid 40’s)
Duration: Variable
Symptoms: See List
Menstrual cycles become irregular with the gap between cycles varying by 7 days or less. This pattern must repeat within 10 cycles to signal menopause.
Levels of FSH are elevated but fluctuate, while levels of AMH and AFC are low. These hormonal changes reflect the declining ovarian function typical of this transition period.
- Stage -1: Late Menopause transition – (Mid 40’s to early 50’s)
Duration: typically lasts 1-3 years
Symptoms: See List
This stage is characterised by the absence of menstruation (amenorrhea), for 60 days or more. During this period, menstrual cycles become irregular, with significant fluctuations in hormone levels and frequent anovulation (no ovulation/egg release).
FSH levels can vary widely during this stage. They may be high, indicating menopause, or low if estradiol is high, which can suppress FSH levels. AMH drops to very low or undetectable levels.
This stage signifies that the body is nearing the end of its reproductive years.
- Stage -2: Early Menopause transition – (Early to mid 40’s)
-
-
Menopause
Menopause (0): is defined as the final menstrual period (FMP) and is confirmed after 12 consecutive months without menstruation, typically occurring in women in their late 40s to early 50s; this pivotal moment is marked by significant hormonal changes, including a sharp decline in estradiol levels and a rise in follicle-stimulating hormone (FSH) levels.
-
Postmenopause Phase:
Duration: 5-8 years
Symptoms: See List
Menopause, typically occurring at an average age of 51 in Western countries, marks the final menstrual period (FMP) and is confirmed after 12 months without menstruation. During this time, FSH levels continue to rise while estradiol levels fall, with these hormonal changes stabilizing approximately two years after the FMP. Following menopause, women enter the postmenopausal phase, which is divided into early and late stages, with Early Menopause further subdivided into 3 sub-stages.
-
-
Stage +1: Early Postmenopause: (Early to mid 50’s)
Postmenopause is the phase that follows menopause and is divided into early and late stages, with Early Menopause having 3 sub-stages.- Stage +1a: (First year postmenopause)
This stage marks the initial 12 months after the final menstrual period. Hormone levels, particularly estradiol, drop significantly, often leading to intense symptoms like hot flashes and night sweats. Women may begin experiencing changes in bone density and face an increased risk of cardiovascular issues. - Stage +1b: (Second year postmenopause)
During the second year, some women may notice a decrease in the intensity of symptoms like hot flashes. Hormone levels stabilize at lower levels as the body continues adjusting to the absence of menstrual cycles. This period is crucial for focusing on bone health due to the increasing risk of osteoporosis. - Stage +1c: (3 to 6 years postmenopause)
By this stage, the body has largely adapted to postmenopausal hormone levels. While vasomotor symptoms may persist, they are generally less severe. The focus shifts more prominently to long-term health concerns, such as bone density loss and cardiovascular disease, necessitating ongoing monitoring and preventive care.
- Stage +1a: (First year postmenopause)
Stage +2: Late postmenopause: (Mid 50’s onwards)
Duration: Remaining lifespanThis stage represents the remaining lifespan after menopause, typically beginning in the mid-50s and extending for the rest of a woman’s life.
Hormonal levels stabilise as the body adjusts to low levels of reproductive hormones.While menopausal symptoms usually subside, aging-related issues become increasingly prevalent. Women may experience symptoms of genitourinary syndrome of menopause (GSM), such as vaginal dryness, thinning of the vaginal lining, and urinary symptoms due to low estrogen levels.
Although average FSH levels may decrease many years after menopause in very elderly individuals, this remains a high-risk phase for women.
The decreased estrogen levels increase the risk of developing osteoporosis, cardiovascular disease (CVD), dementia, Alzheimer’s disease (AD), and cancer. This necessitates ongoing healthcare management to address these potential health concerns.
-
-
-
Symptoms Across Menopause Phases
These lists provide an overview of common symptoms associated with the phases of menopause. However, they are for informational purposes only, and they are not exhaustive, and are not a substitute for professional medical advice, diagnosis, or treatment. Menopause symptoms vary widely among women, differing in both severity and type. For this reason, if you experience these symptoms or have health concerns, consult a healthcare professional
- Cramps: Pain in the lower abdomen, often due to uterine contractions.
- Bloating: Swelling or feeling of fullness in the abdomen.
- Breast Tenderness: Soreness or swelling in the breasts.
- Headaches: Often linked to hormonal changes.
- Fatigue: Feeling unusually tired or lacking energy.
- Mood Swings: Emotional fluctuations related to hormonal changes.
VASOMOTOR SYMPTOM These symptoms are related to changes in blood flow and often include:
- Hot Flashes: Sudden feelings of warmth, often with sweating.
- Night Sweats: Excessive sweating during sleep that can lead to disrupted rest.
- Chills: Feeling of coldness or shivering, sometimes following a hot flash.
MOOD DISTURBANCES (Psychological Dysfunction) These refer to emotional or psychological symptoms such as:
- Depression: Persistent feelings of sadness or loss of interest.
- Anxiety: Excessive worry or nervousness.
- Irritability: Increased sensitivity or agitation.
- Mood Swings: Rapid and intense fluctuations in mood.
COGNITIVE DYSFUNCTION These symptoms impact cognitive functions and may include:
- Memory Problems: Difficulty recalling information or recent events.
- Concentration Issues: Trouble focusing or paying attention.
- Confusion: Difficulty understanding or processing information.
SEXUAL DYSFUNCTION These symptoms affect sexual health and function and can include:
- Decreased Libido: Reduced interest in sexual activity.
- Difficulty with Arousal: Trouble achieving or maintaining sexual arousal.
- Orgasm Issues: Difficulty reaching orgasm or experiencing less pleasure.
SOMATIC SYMPTOMS These are physical symptoms that can include:
- Muscle Aches: General soreness or stiffness in muscles.
- Joint Pain: Discomfort in the joints.
- Digestive Issues: Problems like nausea or constipation.
- Fatigue: Persistent tiredness or lack of energy.
URINARY SYMPTOM These symptoms involve issues with the urinary system, such as:
- Frequent Urination: Needing to urinate more often than usual.
- Urgency: Sudden, strong need to urinate.
- Incontinence: Uncontrolled leakage of urine.
WEIGHT GAIN This can be a general increase in body weight and may be influenced by various factors such as:
- Hormonal Changes: Fluctuations in hormones that can affect appetite and metabolism.
- Fluid Retention: Holding onto excess water in the body.
- Changes in Activity Levels: Reduced physical activity or changes in exercise routine.
GENITAL ATROPHY Genital atrophy, also known as vaginal atrophy, is a condition where the tissues of the vagina and surrounding area (vulva) become thinner, drier, and less elastic. This usually occurs due to a decrease in estrogen levels, particularly during menopause. Symptoms may include:
- Dryness: The vagina may feel dry or irritated.
- Itching: Persistent itching in the vaginal area.
- Burning Sensation: A feeling of burning in the vaginal region.
- Discomfort During Intercourse: Pain or discomfort during sexual activity due to reduced lubrication.
URINARY TRACT ATROPHY Urinary tract atrophy refers to the thinning, drying, and weakening of the tissues in the urinary tract, often related to decreased estrogen levels, particularly during and after menopause. This can lead to various symptoms, such as:
- Frequent Urination: An increased need to urinate.
- Urinary Urgency: A sudden, strong urge to urinate.
- Urinary Incontinence: Leakage of urine, especially during activities like coughing or sneezing.
- Increased Risk of UTIs: The weakened tissues may make urinary tract infections more common.
PELVIC ORGAN PROLAPSE Pelvic organ prolapse occurs when one or more of the pelvic organs (such as the bladder, uterus, or rectum) drop from their normal position and press against the vaginal walls. This condition can result from weakened pelvic floor muscles, often due to childbirth, aging, or other factors. Symptoms may include:
- Pressure or Heaviness: A feeling of pressure or heaviness in the pelvic area.
- Bulging in the Vagina: A noticeable bulge or protrusion in the vaginal area.
- Discomfort During Intercourse: Pain or discomfort during sexual activity.
- Urinary Issues: Problems like difficulty urinating or increased frequency.
SKIN CHANGES: DRY, ITCHY SKIN As the body ages, especially during menopause, skin can become drier and more prone to itching. These changes are often due to a decrease in estrogen, which affects the skin’s ability to retain moisture. Symptoms of these skin changes can include:
- Dryness: The skin may become flaky, rough, or scaly.
- Itching: Persistent itching, which can lead to scratching and further irritation.
- Thin Skin: The skin may become thinner and more fragile, increasing the risk of bruises or cuts.
- Sensitivity: The skin may become more sensitive to products or environmental factors.
- Bone Weakness: Increased fragility of bones, making them more prone to fractures.
- Joint Pain: Discomfort or pain in the joints, often due to decreased bone density.
- Height Loss: Gradual loss of height due to spinal bone weakening.
CARDIOVASCULAR EFFECTS Cardiovascular effects refer to the impact on the heart and blood vessels. In late menopause, the risk of cardiovascular issues can increase due to changes in cholesterol levels, blood pressure, and overall heart health. Symptoms and effects may include:
- Increased Cholesterol: Higher levels of LDL (bad cholesterol) and lower levels of HDL (good cholesterol).
- High Blood Pressure: Elevated blood pressure, which can increase the risk of heart disease.
- Heart Palpitations: Irregular or rapid heartbeats that may feel like fluttering.
CNS EFFECTS (Central Nervous System) CNS effects refer to changes or symptoms related to the brain and nervous system. During late menopause, fluctuations in hormones can affect cognitive and emotional health. Symptoms and effects may include:
- Memory Problems: Difficulty with memory retention or recall.
- Mood Changes: Increased susceptibility to mood swings, anxiety, or depression.
- Sleep Disturbances: Difficulty falling or staying asleep, often due to hormonal changes or other menopause-related symptoms.